# Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)

> **NCT06902857** · — · RECRUITING · sponsor: **Istituto Nazionale di Ricovero e Cura per Anziani** · enrollment: 1002 (estimated)

## Conditions studied

- Type 2 Diabetes
- Cardiovascular Complication

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06902857
- **Lead sponsor:** Istituto Nazionale di Ricovero e Cura per Anziani
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-18
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 1002 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06902857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06902857, "Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06902857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*